Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan

被引:187
作者
Hsueh, PR
Chen, WH
Luh, KT
机构
[1] Natl Taiwan Univ Hosp, Coll Med, Dept Lab Med, Taipei 10764, Taiwan
[2] Natl Taiwan Univ Hosp, Coll Med, Dept Internal Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ Hosp, Coll Med, Dept Pharm, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Coll Med, Infect Control Committee, Taipei 10764, Taiwan
关键词
antimicrobial use; antimicrobial resistance; nosocomial infection; Gram-negative bacteria; Taiwan;
D O I
10.1016/j.ijantimicag.2005.08.016
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study was conducted to evaluate the relationship between antimicrobial resistance and antimicrobial use in a university hospital in Taiwan. Disk Susceptibility data of Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Proteus spp., Pseudomonas aeruginosa, Acinetobacter spp., Stenotrophomonas maltophilia and other non-fermentative Gram-negative bacilli causing nosocomial infections were evaluated. Data on annual patient-days and annual consumption (defined daily dose (DDD) per 1000 patient-days) of extended-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, flumoxef, cefepime and cefpirome), beta-lactam-beta-lactamase inhibitor combinations (ticarcillin/clavulanic acid and piperacillin/tazobactam), carbapenems (imipenem and meropenem), aminoglycosides (amikacin, gentamicin and tobramycin), fluoroquinolones (ciprofloxacin (oral and injectable) and oral levofloxacin and moxifloxacin) from 1991 to 2003 were analysed. Increasing trends of incidences of several of these bacteria Causing all nosocomial infections or nosocomial bloodstream infections were noted from 1991 to 2003. The annual patient-days of the hospital significantly increased, from 360 210 in 1991 to 672676 in 2002 (linear regression analysis, P < 0.05), but slightly decreased in 2003 (629 168) owing to the severe acute respiratory syndrome epidemic in Taiwan. The rise in cefotaxime-resistant or ciprofloxacin-resistant E. coli and meropenem-resistant P aeruginosa was significantly correlated with increased consumption of extended-spectrum cephalosporins, beta-lactam-beta-lactamase inhibitor combinations, carbapenems, fluoroquitiolones and aminoglycosides (for ciprofloxacin-resistant E. coli and meropenem-resistant P. aeruginosa only) in the hospital (Pearson's correlation coefficient, r > 0.72 (or <-0.72) and P-value < 0.05). Increased ciprofloxacin-resistant K. pneumoniae and meropenem-resistant Acinetobacter spp. was significantly associated with the increased usage of extended-spectrum cephalosporins but not with the other four classes of antibiotics. This 13-year study in a hospital demonstrated significant changes in antimicrobial use, which may have affected antimicrobial resistance in certain Gram-negative bacteria at the hospital. (c) 2005 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:463 / 472
页数:10
相关论文
共 38 条
[1]   Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections [J].
Allegranzi, B ;
Luzzati, R ;
Luzzani, A ;
Girardini, F ;
Antozzi, L ;
Raiteri, R ;
Di Perri, G ;
Concia, E .
JOURNAL OF HOSPITAL INFECTION, 2002, 52 (02) :136-140
[2]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[3]   Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: Impact on sustained high rates of bacterial resistance [J].
Bantar, C ;
Vesco, E ;
Heft, C ;
Salamone, F ;
Krayeski, M ;
Gomez, H ;
Coassolo, MA ;
Fiorillo, A ;
Franco, D ;
Arango, C ;
Duret, F ;
Oliva, ME .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :392-395
[4]  
FISH DN, 1995, PHARMACOTHERAPY, V15, P279
[5]   Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002 [J].
Flamm, RK ;
Weaver, MK ;
Thornsberry, C ;
Jones, ME ;
Karlowsky, JA ;
Sahm, DF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2431-2436
[6]  
Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P617
[7]   Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections [J].
Fridkin, SK ;
Edwards, JR ;
Tenover, FC ;
Gaynes, RP ;
McGowan, JE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (03) :324-329
[8]   Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2 [J].
Fridkin, SK ;
Steward, CD ;
Edwards, JR ;
Pryor, ER ;
McGowan, JE ;
Archibald, LK ;
Gaynes, RP ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :245-252
[9]   Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes [J].
Friedrich, LV ;
White, RL ;
Bosso, JA .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1017-1024
[10]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140